arsenic has been researched along with Non-alcoholic Fatty Liver Disease in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 8 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Canet, MJ; Cherrington, NJ; Gandolfi, AJ; Hardwick, RN; Klimecki, WT; Kopplin, MJ; Lake, AD; Scheffer, GL | 1 |
| Chen, X; Fu, J; Hu, Y; Pi, J; Wang, H; Wu, H; Wu, R; Xu, Y | 1 |
| Abedini, AH; Esrafili, A; Ghazi-Khansari, M; Irshad, N; Sadighara, P; Yousefi, M | 1 |
| Aimuzi, R; Jiang, Y; Qu, Y; Si, M; Xie, Z | 1 |
| Li, H; Li, W; Li, Z; Liu, Q; Wang, D; Wang, L; Wang, S; Wu, L; Xu, Y; Ye, F; Zhang, A; Zhang, J | 1 |
| Benner, CW; Chang, M; Chen, S; Gordts, PLSM; Karin, M; Le, S; Liu, J; Mennillo, E; Secrest, P; Tukey, RH; Weber, AA; Wong, S; Yang, X | 1 |
| Aschner, M; Bogdanov, AR; Santamaria, A; Skalny, AV; Tinkov, AA; Tizabi, Y; Virgolini, MB; Zhou, JC | 1 |
| Han, Q; Jiang, L; Liu, X; Qiu, T; Shi, Y; Sun, X; Wang, L; Wang, N; Wu, C; Yang, G; Yao, X; Yuan, W | 1 |
| Jia, X; Jiang, L; Liu, S; Liu, X; Qiu, T; Sun, X; Tao, Y; Wang, N; Wei, S; Yang, G; Yao, X; Zhang, J; Zhu, Y | 1 |
| Figueroa, J; Frediani, JK; Marsit, CJ; Naioti, EA; Vos, MB; Welsh, JA | 1 |
| Asprouli, E; Dassenakis, M; Dedoussis, GV; Kalafati, IP; Kalogeropoulos, N; Karavoltsos, S; Kokkinos, A; Revenas, K; Sakellari, A; Vlachogiannakos, J | 1 |
| Bai, J; Gao, N; Jiang, L; Liu, X; Pei, P; Qi, S; Qiu, T; Sun, X; Wang, Z; Wei, S; Yan, R; Yang, G; Yang, L; Yao, X | 1 |
2 review(s) available for arsenic and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Association Between Non-alcoholic Fatty Liver Disease and Heavy Metal Exposure: a Systematic Review.
Topics: Arsenic; Cadmium; Humans; Iron; Mercury; Metals, Heavy; Non-alcoholic Fatty Liver Disease; Zinc | 2023 |
Dissecting the role of cadmium, lead, arsenic, and mercury in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Topics: Arsenic; Cadmium; Humans; Lead; Liver; Mercury; Non-alcoholic Fatty Liver Disease | 2023 |
10 other study(ies) available for arsenic and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Altered arsenic disposition in experimental nonalcoholic fatty liver disease.
Topics: Animals; Arsenates; Arsenic Trioxide; Arsenicals; Biotransformation; Choline Deficiency; Diet, High-Fat; Disease Models, Animal; Environmental Pollutants; Fatty Liver; Kidney; Liver; Male; Methionine; Methyltransferases; Mice; Mice, Inbred C57BL; Multidrug Resistance-Associated Proteins; Non-alcoholic Fatty Liver Disease; Oxides | 2012 |
Integrated miRNA-mRNA analysis reveals the dysregulation of lipid metabolism in mouse liver induced by developmental arsenic exposure.
Topics: Animals; Arsenic; Lipid Metabolism; Lipids; Mice; Mice, Inbred C57BL; MicroRNAs; Non-alcoholic Fatty Liver Disease; RNA, Messenger | 2023 |
Associations of metal mixtures with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2003-2018.
Topics: Adult; Arsenic; Barium; Bayes Theorem; Humans; Molybdenum; Non-alcoholic Fatty Liver Disease; Nutrition Surveys; Obesity; Overweight; Thallium; Tungsten | 2023 |
As3MT via consuming SAM is involved in arsenic-induced nonalcoholic fatty liver disease by blocking m
Topics: Animals; Arsenic; Fatty Acids; Liver; Mice; MicroRNAs; Non-alcoholic Fatty Liver Disease; S-Adenosylmethionine | 2023 |
Effects of Early Life Oral Arsenic Exposure on Intestinal Tract Development and Lipid Homeostasis in Neonatal Mice: Implications for NAFLD Development.
Topics: Animals; Animals, Newborn; Arsenic; Dietary Fats; Homeostasis; Mice; Non-alcoholic Fatty Liver Disease | 2023 |
Filamin A facilitates NLRP3 inflammasome activation during arsenic-induced nonalcoholic steatohepatitis.
Topics: Animals; Arsenic; Filamins; Inflammasomes; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; NLR Proteins; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley | 2023 |
Ferroptosis mediated by the interaction between Mfn2 and IREα promotes arsenic-induced nonalcoholic steatohepatitis.
Topics: Animals; Arsenic; Coenzyme A Ligases; Endoribonucleases; Ferroptosis; GTP Phosphohydrolases; Mitochondrial Proteins; Multienzyme Complexes; Non-alcoholic Fatty Liver Disease; Protein Serine-Threonine Kinases; Rats | 2020 |
Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005-2014.
Topics: Adolescent; Adult; Alanine Transaminase; Arsenic; Biomarkers; Cross-Sectional Studies; Environmental Exposure; Environmental Pollutants; Female; Hispanic or Latino; Humans; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Nutrition Surveys; Odds Ratio; Risk; United States; Young Adult | 2018 |
Evaluation of Plasma Trace Elements in Different Stages of Nonalcoholic Fatty Liver Disease.
Topics: Adult; Arsenic; Biomarkers; Body Mass Index; Case-Control Studies; Disease Progression; Female; Greece; Humans; Insulin; Linear Models; Liver Function Tests; Male; Metals, Heavy; Middle Aged; Non-alcoholic Fatty Liver Disease; Severity of Illness Index; Surveys and Questionnaires; Trace Elements | 2019 |
Taurine attenuates arsenic-induced pyroptosis and nonalcoholic steatohepatitis by inhibiting the autophagic-inflammasomal pathway.
Topics: Animals; Arsenic; Autophagy; Cell Survival; Hep G2 Cells; Humans; Inflammation; Mice; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Non-alcoholic Fatty Liver Disease; Pyroptosis; Real-Time Polymerase Chain Reaction; Signal Transduction; Taurine | 2018 |